Athenex Provides Update from FDA Type A Meeting Regarding Oral Paclitaxel + Encequidar in Metastatic Breast Cancer

NEXT STORY
Global Human Growth Hormone Drugs Market to Reach $4 Billion by 2026
PREV STORY
Zai Lab Announces Upcoming Presentations in October Investor Conferences
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Arcutis Submits Topical Roflumilast Cream New Drug Application to FDA for the Treatment of Adults and Adolescents with Plaque Psoriasis

author_avatar
NASDAQ Market News

Final Results of Albireo’s Phase 2 Study of A4250 in Children with Cholestatic Liver Disease to be Presented at The Liver Meeting® 2017

BOSTON, Oct. 03, 2017 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (Nasdaq:ALBO), a clinical-stage orphan ...

author_avatar
NASDAQ Market News

The Board of Directors of Orion Corporation decided on an incentive plan for key persons

                                                                         ORION CORPORATION  STOCK EXCHANGE RELEASE    2 FEB 2016  AT 14:45 PM EET               ...

author_avatar
NASDAQ Market News